Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
JP Stock MarketDetailed Quotes
4565 Nxera Pharma
- 934
- +18+1.97%
20min DelayMarket Closed May 2 15:30 JST
83.97BMarket Cap-17.32P/E (Static)
947High906Low1.06MVolume914Open916Pre Close983.01MTurnover175452wk High1.48%Turnover Ratio89.90MShares66852wk Low-53.92EPS TTM66.74BFloat Cap6545Historical HighLossP/E (Static)71.45MShs Float23Historical Low-53.92EPS LYR4.48%Amplitude--Dividend TTM1.23P/B100Lot Size--Div YieldTTM
Nxera Pharma News
Nxera Pharma: Business highlights and consolidated financial results for the first quarter (January-March) of the fiscal year ending 2025/12
Nxera Pharma: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [IFRS] (consolidated)
Nxera Pharma: Extraordinary Report
Nxera Pharma: Interim report.
Nxera Pharma: Confirmation
Nxera Pharma: Financial Report - 35th Term (2024/01/01 - 2024/12/31)
Nxera Pharma: Notice regarding differences between consolidated results for the fiscal year ending 2024/12 and consolidated results for the previous fiscal year
Nxera Pharma: Business highlights and consolidated financial results for the fiscal year ending 2024/12 (January-December)
Nxera Pharma: Summary of financial results for the fiscal year ending 2024/12 [IFRS] (consolidated)
Nxera Pharma: Business highlights and consolidated financial results for the 3rd quarter (January-September) of the fiscal year ending 2024/12
Nxera Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
Nxera Pharma: Confirmatory letter.
Nxera Pharma: Interim report - 35th period (01/01/2024 - 12/31/2024)
Nxera Pharma: Business highlights and consolidated performance for the second quarter (interim period) of December 2024 (January-June).
Nxera Pharma: December 2024, second quarter (interim period) financial results announcement [IFRS] (consolidated).
Sosei Group: Confirmation letter
Sosei Group: Quarterly Report - 35th Quarter 1 (2024/01/01 to 2024/03/31)
Sosei Group: Business highlights and consolidated financial results for the first quarter (January-March) of the fiscal year ending 2024/12
Sosei Group: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
Sosei Group: Extraordinary Report
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts